![]() | ![]() |
Formats:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2006, Biophysical Society Analysis of a Generic Model of Eukaryotic Cell-Cycle Regulation *Department of Biological Sciences, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0406; and †Molecular Network Dynamics Research Group of the Hungarian Academy of Sciences and Department of Agricultural and Chemical Technology, Budapest University of Technology and Economics, H-1521 Budapest, Hungary Address reprint requests to John J. Tyson, Tel.: 540-231-4662; Fax: 540-231-9307; E-mail: tyson/at/vt.edu; or Attila Csikász-Nagy, E-mail: csikasz/at/mail.bme.hu. Received January 12, 2006; Accepted March 16, 2006. This article has been cited by other articles in PMC.Abstract We propose a protein interaction network for the regulation of DNA synthesis and mitosis that emphasizes the universality of the regulatory system among eukaryotic cells. The idiosyncrasies of cell cycle regulation in particular organisms can be attributed, we claim, to specific settings of rate constants in the dynamic network of chemical reactions. The values of these rate constants are determined ultimately by the genetic makeup of an organism. To support these claims, we convert the reaction mechanism into a set of governing kinetic equations and provide parameter values (specific to budding yeast, fission yeast, frog eggs, and mammalian cells) that account for many curious features of cell cycle regulation in these organisms. Using one-parameter bifurcation diagrams, we show how overall cell growth drives progression through the cell cycle, how cell-size homeostasis can be achieved by two different strategies, and how mutations remodel bifurcation diagrams and create unusual cell-division phenotypes. The relation between gene dosage and phenotype can be summarized compactly in two-parameter bifurcation diagrams. Our approach provides a theoretical framework in which to understand both the universality and particularity of cell cycle regulation, and to construct, in modular fashion, increasingly complex models of the networks controlling cell growth and division. INTRODUCTION The cell cycle is the sequence of events by which a cell replicates its genome and distributes the copies evenly to two daughter cells. In most cells, the DNA replication-division cycle is coupled to the duplication of all other components of the cell (ribosomes, membranes, metabolic machinery, etc.), so that the interdivision time of the cell is identical to its mass doubling time (1,2). Usually mass doubling is the slower process; hence, temporal gaps (G1 and G2) are inserted in the cell cycle between S phase (DNA synthesis) and M phase (mitosis). During G1 and G2 phases, the cell is growing and “preparing” for the next major event of the DNA cycle (3). “Surveillance mechanisms” monitor progress through the cell cycle and stop the cell at crucial “checkpoints” so that events of the DNA and growth cycles do not get out of order or out of balance (4,5). In particular, in protists (for sure) and metazoans (to a lesser extent), cells must grow to a critical size to start S phase and to a larger size to enter mitosis. These checkpoint requirements assure that the cycle of DNA synthesis and mitosis will keep pace with the overall growth of cells (6). Other checkpoint signals monitor DNA damage and repair, completion of DNA replication, and congression of replicated chromosomes to the metaphase plate (7). Eukaryotic cell cycle engine These interdependent processes are choreographed by a complex network of interacting genes and proteins. The main components of this network are cyclin-dependent protein kinases (Cdk's), which initiate crucial events of the cell cycle by phosphorylating specific protein targets. Cdk's are active only if bound to a cyclin partner. Yeasts have only one essential Cdk, which can induce both S and M phase depending on which type of cyclin it binds. Because Cdk molecules are always present in excess, it is the availability of cyclins that determines the number of Cdk/cyclin complexes in a cell (8). Cdk/cyclin complexes can be downregulated a), by inhibitory phosphoryation of the Cdk subunit and b), by binding to a stoichiometric inhibitor (cyclin-dependent kinase inhibitor (CKI)) (9). Some years ago Paul Nurse (10) proposed, and since then many experimental studies have confirmed, that the DNA replication-division cycle in all eukaryotic cells is controlled by a common set of proteins interacting with each other by a common set of rules. Nonetheless, each particular organism seems to use its own peculiar mix of these proteins and interactions, generating its own idiosyncrasies of cell growth and division. The “generic” features of cell cycle control concern these common genes and proteins and the general dynamical principles by which they orchestrate the replication and partitioning of the genome from mother cell to daughter. The peculiarities of the cell cycle concern exactly which parts of the common machinery are functioning in any given cell type, given the genetic background and developmental stage of an organism. We formulate the genericity of cell cycle regulation in terms of an “underlying” set of nonlinear ordinary differential equations with unspecified kinetic parameters, and we attribute the peculiarities of specific organisms to the precise settings of these parameters. Using bifurcation diagrams, we show how specific physiological features of the cell cycle are determined ultimately by levels of gene expression. Mathematical modeling of the cell cycle The dynamic properties of complex regulatory networks cannot be reliably characterized by intuitive reasoning alone. Computers can help us to understand and predict the behavior of such networks, and differential equations (DEs) provide a convenient language for expressing the meaning of a molecular wiring diagram in computer-readable form (11). Numerical solutions of the DEs can be compared with experimental results, in an effort to determine the kinetic rate constants in the model and to confirm the adequacy of the wiring diagram. Eventually the model, with correct equations and rate constants, should give accurate simulations of known experimental results and should be pressed to make verifiable predictions. This method has been used for many years to create mathematical models of eukaryotic cell cycle regulation (12–29). The greatest drawback to DE-based modeling is that the modeler must estimate all the rate constants from the available data and still have some observations “left over” to test the model. In the case of cell cycle regulation, very few of these rate constants have been measured directly (30,31) although the available data provide severe constraints on rate constant values (15,32). To complement the important but tedious work of parameter estimation by data fitting, we need analytical tools for characterizing the parameter-dependence of solutions of DEs and for associating a model's robust dynamical properties to the physiological characteristics of living cells. Bifurcation theory and regulatory networks Bifurcation theory is a general tool for classifying the attractors of a dynamical system and describing how the qualitative properties of these attractors change as a parameter value changes. Bifurcation theory has been used successfully to understand transitions in the cell cycle by our group (33–37) and by others (12,26,38). In this article, we use bifurcation theory to examine a generic model of eukaryotic cell cycle controls, bringing out the similarities and differences in the dynamical regulation of cell cycle events in yeasts, frog eggs, and mammalian cells. To understand our approach, the reader must be familiar with a few elementary bifurcations of nonlinear DEs and how they are generated by positive and negative feedback in the underlying molecular network. For more details, the reader may consult the Appendix to this article and some recent review articles (36,37). MATERIALS AND METHODS In Fig. 1
For numerical simulations and bifurcation analysis of the DEs, we used the computer program XPP-AUT (42), with the “stiff” integrator. Instructions on how to reproduce our simulations and diagrams (including all necessary .ode and .set files, and an optional SBML version of the model) can be downloaded from our website (43). All protein concentrations in the model are expressed in arbitrary units (au) because, for the most part, we do not know the actual concentrations of most regulatory proteins in the cell. Hence, all rate constants capture only the timescales of processes (rate constant units are min−1). For each mutant, we use the same equations and parameter values except for those rate constants that are changed by the mutation (e.g., for gene deletion we set the synthesis rate of the associated protein to zero). RESULTS A generic model of cell cycle regulation Since the advent of gene-cloning technologies in the 1980s, molecular cell biologists have been astoundingly successful in unraveling the complex networks of genes and proteins that underlie major aspects of cell physiology. These results have been collected recently in comprehensive molecular interaction maps (44–48). In the same spirit, but with an eye toward a computable, dynamic model, we collected the most important regulatory “modules” of the Cdk network. Our goal is to describe a generic network (Fig. 1 Regulatory modules The network, which tracks the three principal cyclin families (cyclins A, B, and E) and the proteins that regulate them at the G1-S, G2-M, and M-G1 transitions, can be subdivided into 13 modules. (Other, coarser subdivisions are possible, but these 13 modules are convenient for describing the similarities and differences of regulatory signals among various organisms.) Modules 4, 10, and 13: synthesis and degradation of cyclins B, E, and A. Cyclin E is active primarily at the G1-S transition, cyclin A is active from S phase to early M phase, and cyclin B is essential for mitosis. Modules 1 and 2: regulation of the anaphase promoting complex (APC). The APC works in conjunction with Cdc20 and Cdh1 to ubiquitinylate cyclin B, thereby labeling it for degradation by proteasomes. The APC must be phosphorylated by the mitotic CycB kinase before it will associate readily with Cdc20, but not so with Cdh1. On the other hand, Cdh1 can be inactivated by phosphorylation by cyclin-dependent kinases. Cdc14 is a phosphatase that opposes Cdk by dephosphorylating and activating Cdh1. Module 8: synthesis and degradation of CKI (cyclin-dependent kinase inhibitor). Degradation of CKI is promoted by phosphorylation by cyclin-dependent kinases and inhibited by Cdc14 phosphatase. Modules 6, 9, and 12: reversible binding of CKI to cyclin/Cdk dimers to produce catalytically inactive trimers (stoichiometric inhibition). Modules 3, 7, and 11: regulation of the transcription factors that drive expression of cyclins and CKI. TFB is activated by cyclin B-dependent kinase. TFE is activated by some cyclin-dependent kinases and inhibited by others. TFI is inhibited by cyclin B-dependent kinase and activated by Cdc14 phosphatase. Module 5: regulation of cyclin B-dependent kinase by tyrosine phosphorylation and dephosphorylation (by Wee1 kinase and Cdc25 phosphatase, respectively). The tyrosine-phosphorylated form is less active than the unphosphorylated form. Cyclin B-dependent kinase phosphorylates both Wee1 (inactivating it) and Cdc25 (activating it), and these phosphorylations are reversed by Cdc14 phosphatase. The model is replete with positive feedback loops (CycB activates TFB, which drives synthesis of CycB; CycB activates Cdc25, which activates CycB; CKI inhibits CycB, which promotes degradation of CKI; Cdh1 degrades CycB, which inhibits Cdh1), and negative feedback loops (CycB activates APC, which activates Cdc20, which degrades CycB; CycB activates Cdc20, which activates Cdc14, which opposes CycB; TFE drives synthesis of CycA, which inhibits TFE). These complex, interwoven feedback loops create the interesting dynamical properties of the control system, which account for the characteristic features of cell cycle regulation, as we intend to show. The model (at present) neglects important pathways that regulate, e.g., cell proliferation in metazoans (retinoblastoma protein), mitotic exit in yeasts (the FEAR, MEN, and SIN pathways), and the ubiquitous DNA-damage and spindle assembly checkpoints. We intend to remedy these deficiencies in later publications, as we systematically grow the model to include more and more features of the control system. Role of cell growth In yeasts and other lower eukaryotes, a great deal of evidence shows the dominant role of cell growth in setting the tempo of cell division (2,49–52). In somatic cells of higher eukaryotes there are many reports of size control of cell-cycle events (e.g., (53–55)), although other authors have cast doubts on a regulatory role for cell size (e.g., (56,57)). For embryonic cells and cell extracts, the activation of Cdk1 is clearly dependent on the total amount of cyclin B available (58,59). To create a role for cell size in the regulation of Cdk activities, we assume, in our models, that the rates of synthesis of cyclins A, B, and E are proportional to cell “mass”. The idea behind this assumption (see also Futcher (60)) is that cyclins are synthesized in the cytoplasm on ribosomes at an increasing rate as the cell grows. The cyclins then find a Cdk partner and move into the nucleus where they perform their functions. Presumably the effective, intranuclear concentrations of the cyclin-dependent kinases increase as the cell grows because they become more concentrated at their sites of action. Other regulatory proteins in the network, we assume, are not compartmentalized in the same way, so their effective concentrations do not increase as the cell grows. This basic idea for size control of the cell cycle was tested experimentally in budding yeast by manipulating the “nuclear localization signals” on cyclin proteins (8). As predicted by the model, cell size is larger in cells that exclude cyclins from the nucleus and smaller in cells that overaccumulate cyclins in the nucleus. A recent theoretical study by Yang et al. (61) may shed light on how cell size couples to cell division without assuming a direct dependence of cyclin synthesis rate on mass, but, for this article, we adopt the assumption as a simple and effective way to incorporate size control into nonlinear DE models for the control of cyclin-dependent kinase activities. For simplicity, we assume that cell mass increases exponentially (with a mass doubling time (MDT) suitable for the organism under consideration) and that cell mass is exactly halved at division. Our qualitative results (bifurcation diagrams, etc.) are not dependent on these assumptions. Cell growth may be linear or logistic, and cell division may be asymmetric or inexact—it doesn't really matter to our models. The important features are that “mass” increases monotonically as the cell grows (driving the control system through bifurcations that govern events of the cell cycle) and that mass decreases abruptly at cell division (resetting the control system back to a G1-like state—unreplicated chromosomes and low Cdk activity). Equations and parameter values The dynamical properties of the regulatory network in Fig. 1 Frog embryos: Xenopus laevis To validate our equations and tools, we first verified our earliest studies of bifurcations in the frog-egg model. The combination of modules 1, 4, and 5 of Fig. 1 Fission yeast: Schizosaccharomyces pombe Wild-type cell cycle The fission yeast cell cycle network, composed of modules 1, 2, 4, 5, 6, 8, 11, 12, and 13, is described in Fig. 2
The gray trajectory in Fig. 2 A Overshoot of a SNIPER bifurcation point (as in Fig. 2 A The one-parameter bifurcation diagram in Fig. 2 A A satisfactory model of fission yeast must account not only for the phenotype of wild-type cells but also for the unusual properties of the classic cdc and wee mutants that played such important roles in deducing the cell-cycle control network. Mutations change the values of specific rate constants, which remodel the one-parameter bifurcation diagram and thereby change the way a cell progresses through the DNA replication-division cycle. For example (Fig. 3 A
In the Supplementary Material (Fig. S2) we present bifurcation diagrams for four other fission yeast mutants (cig2Δ, cig2Δ rum1Δ, wee1Δ cdc25Δ, wee1Δ rum1Δ), to confirm that our “generic” version is indeed consistent with the known physiology of these mutants. Because they have been described in detail elsewhere (37), we turn our attention instead to some novel results. Endoreplicating mutants On the wild-type bifurcation diagram (Fig. 2 A In Fig. 4 A
Mutant analysis on the genetics-physiology plane In our view, genetic mutations are connected to cell phenotypes through bifurcation diagrams. Mutations induce changes in parameter values, which may change the nature of the bifurcations experienced by the control system, which will have observable consequences in the cell's physiology. Mutation-induced changes in parameter values may be large or small: e.g., the rate constant for CycB synthesis = 0 in a cdc13Δ cell, but a wee1ts (“temperature sensitive”) mutant may cause only a minor change in the catalytic activity of Wee1 kinase. Whether these changed parameter values cause a qualitative change in bifurcation points on the one-parameter diagram (Figs. 2 A To illustrate this idea, we first consider wee1 mutations. On the two-parameter bifurcation diagram in Fig. 3 B The two-parameter bifurcation diagram for cyclin B (Cdc13) expression (Fig. 4 B The two-parameter bifurcation diagrams in Figs. 3 Budding yeast: Saccharomyces cerevisiae Our generic model of the budding yeast cell cycle is based on a detailed model published recently by Chen et al. (15). The generic model bypasses details of the mitotic exit network (MEN) in Chen's model, assuming instead that Cdc20 directly activates Cdc14. We had to change some parameters compared to Chen et al. (15) because of this and other minor changes in the network. We found these new parameter values by fitting simulations of wild-type and some mutant cells (15). Wild-type cells One-dimensional bifurcation diagrams of wild-type cells created by the full model (15) and by our generic model (Fig. 5, A and B
Two ways to achieve size homeostasis Fig. 5 A Fig. 6
Cell cycles that visit the “sizer” domain (top two curves in Fig. 6 As Fig. 6 Mutants of G1 phase regulation In this section we present bifurcation diagrams for a few of the most important and interesting mutants described in great detail by numerical simulations in Chen et al. (15). We start with mutants missing the components that stabilize the G1 phase of the cell cycle: either Cdh1 (an activator of CycB degradation) (Fig. 5 C Two-parameter bifurcation diagrams (genetic-physiology planes) for both SIC1 and CDH1 are presented in the Supplementary Material (Fig. S3). The two types of mutations have quite a similar effect on cell physiology. Mutants of mitotic exit regulation Although both cdc20ts and cdc14ts mutants block mitotic exit, cdc20ts arrests at the metaphase-anaphase transition (75), whereas cdc14ts arrests in telophase (76,77). Hence, exit from mitosis must be a two-stage process (30), with two different stable-steady states in which the control system can halt. The one-parameter bifurcation diagrams (Fig. 5, E and F Lethality that depends on growth rate To bind effectively to Cdc20, proteins of the core APC need to be phosphorylated (78). If these phosphorylation sites are mutated to nonphosphorylable alanine residues (the mutant is called APC-A), then Cdc20-mediated degradation of CycB is compromised, although the APC-A cells are still viable. We assume that APC-A has a constant activity that is 10% of the maximum activity of the normally phosphorylated form of APC in conjunction with Cdc20. Furthermore, we assume that APC-A has full activity in conjunction with Cdh1, in accord with the evidence (78). In simulations (Fig. 7 A
Double mutant cells, APC-A cdh1Δ, are lethal at fast growth rates but partially viable at slow growth rates (30). Our bifurcation diagram (Fig. 7 B The same dependence of viability on growth conditions was reported for CLB2dbΔ clb5Δ mutant cells (CycB stablized, CycA absent) (30,80), and is illustrated in our bifurcation diagram (Fig. 7 D All of these mutations interfere with the negative feedback loop of CycB degradation. Weak negative feedback creates long-period oscillations that are stable attractors only at relatively small cell mass; at large mass the activity of CycB-dependent kinase is so strong that the mutant cells arrest in mitosis. Fast growing cells cannot find a period of oscillation that balances their MDT, so they overgrow the oscillatory region and get stuck in mitosis. These results suggest that other mutants affecting the negative feedback loop should be reinvestigated to see if viability depends on growth rate (for example, APC-A sic1Δ and cdc20ts pds1Δ). Cells that show this sensitivity to growth rate are also likely to be sensitive to random noise in the control system. Using a model similar to ours, Battogtokh and Tyson (34) showed that, for control systems operating close to a bifurcation to the stable M-like steady state, cells might get stuck in mitosis after a few cycles if a little noise is added to the system. This effect would show up as partial viability of a clone at intermediate growth rates. Incorporation of the morphogenetic checkpoint In modeling the budding yeast cell cycle so far, we have assumed that the G2 module of Cdk phosphorylation (module 5 in Fig. 1 Mammalian cells Many groups have modeled various aspects of the molecular machinery controlling mammalian cell cycles (22,26,84,85), including us (41). In this article, we insert parameter values from Novak and Tyson (41) into our generic model to simulate a “generic mammalian cell” (Fig. 8
It has been recently discovered that mouse embryos deleted of all forms of CycD (86), deleted of both forms of CycE (87), or deleted of both Cdk4 and Cdk6 (88) can develop until late stages of embryogenesis and die from causes unrelated to the core cell cycle machinery. Mice lacking Cdk2 are viable (89), and mouse embryo fibroblast from any of these mutants proliferate normally. Our model is expected to reproduce these results. Indeed, simulation of CycE-deleted cells show almost no defect in proliferation with a cell division mass 1.2 times wild-type cells (Supplementary Material, Fig. S5 C). The absence of CycD has a greater effect on the system, creating cycles with a division mass 3.6 times wild-type (Fig. 8 C From Chow et al. (92) we know that, although phosphorylation of Cdk2 (in complexes with CycE or CycA) plays no major role in unperturbed proliferation of HeLa cells, phosphorylation of Cdk1/CycB by Wee1 plays a role in normal cell cycling. These reactions (module 5 in Fig. 1 With the G2-regulatory module in place, our model is now set up for serious consideration of the major checkpoint controls in mammalian cells: 1), restriction point control, by which cyclin D and retinoblastoma protein regulate the activity of transcription factor E; 2), the DNA-damage checkpoint in G1, which upregulates the production of CKI; 3), the unreplicated-DNA checkpoint in G2, which activates Wee1 and inhibits Cdc25; and 4), the chromosome misalignment checkpoint in M phase, which silences Cdc20. Building appropriate modules for these checkpoints and wiring them into the generic cell cycle engine will be topics for future publications and will provide a basis for modeling the hallmarks of cancer (93). DISCUSSION We propose a protein interaction network for eukaryotic cell cycle regulation that 1), includes most of the important regulatory proteins found in all eukaryotes, and 2), can be parameterized to yield accurate models of a variety of specific organisms (budding yeast, fission yeast, frog eggs, and mammalian cells). The model is built in modular fashion: there are four synthesis-and-degradation modules (“4, 8, 10, 13”), three stoichiometric binding-and-inhibition modules (“6, 9, 12”), three transcription factor modules (“3, 7, 11”), and three modules with multiple activation-and-inhibition steps (“1, 2, 5”). This modularity assists us to craft models for specific organisms (where some modules are more important than others) and to extend models with new modules embodying the signaling pathways that impinge on the underlying cell cycle engine. To describe the differences in regulatory networks in yeasts, frog eggs, and mammalian cells, we subdivided the generic wiring diagram (Fig. 1 The many different control loops in the “generic” model can be mixed and matched to create explicit models of specific organisms and mutants. In this sense, there is no “ideal” or “simplest” model of the cell cycle. Each organism has its own idiosyncratic properties of cell growth and division, depending on which modules are in operation, which depends ultimately on the genetic makeup of the organism. Lethal mutations push the organism into a region of parameter space where the control system is no longer viable. To deepen our understanding of the similarities and differences in cell cycle regulation in different types of cells, we analyzed our models of specific organisms and mutants with bifurcation diagrams. To show how cell growth drives transitions between cell cycle phases (G1/S/G2/M), we employ one-parameter bifurcations diagrams, where stable steady states correspond to available arrest states of the cell cycle (late G1, late G2, metaphase) and saddle-node and SNIPER bifurcation points identify critical cell sizes for leaving an arrest state and proceeding to the next phase of the cell cycle. In this view, cell cycle “checkpoints” (also called “surveillance” mechanisms) (4,5) respond to potential problems in cell cycle progression (DNA damage, delayed replication, spindle defects) by stabilizing an arrest state, i.e., by putting off the bifurcation to much larger size than normal (18,37,40,84,94). The most important type of bifurcation, we believe, is a “SNIPER” bifurcation, by which a stable steady state (G1 or G2) gives rise to a limit cycle solution that drives the cell into mitosis and then back to G1 phase. At the SNIPER bifurcation, the period of the limit cycle oscillations is initially infinite but drops rapidly as the cell grows larger. SNIPER bifurcations are robust properties of nonlinear control systems with both positive and negative feedback. Not only are they commonly observed in one-parameter bifurcation diagrams of the Cdk network, but they persist over large ranges of parameter variations, as is evident from our two-parameter bifurcation diagrams. For example, in Figs. 3 B The SNIPER bifurcation is very effective in achieving a balance between progression through the cell cycle (interdivision time (IDT)) and overall cell growth (mass doubling time (MDT)). Cell size homeostasis means that IDT = MDT. In Fig. 6 One-parameter bifurcations diagrams succinctly capture the dependence of the cell cycle engine (Cdk/CycB activity) on cell growth and division (cell mass changes). By superimposing cell cycle trajectories on the one-parameter bifurcation diagram, we have shown how SNIPER bifurcations orchestrate the balance between cell growth and progression through the chromosome replication cycle. In a two-parameter bifurcation diagram, we suppress the display of Cdk/CycB activity (i.e., the state of the engine) and use the second dimension to display a genetic characteristic of the control system (i.e., the level of expression of a gene, from zero, to normal, to overexpression). On the two-parameter diagram we see how the orchestrating SNIPER bifurcations change in response to mutations, and consequently how the phenotype of the organism (viability/inviability and cell size) depends on its genotype. The two-parameter bifurcation diagram can be used not only to obtain an overview of known phenotypes but also to predict potentially unusual phenotypes of cells with intermediate levels of gene expression. Our model is freely available to interested users in three forms. From the web site (69) one can download .ode and .set files for use with the free software XPP-AUT. From an .ode file one can easily generate FORTRAN or C++ subroutines, or port the model to Matlab or Mathematica. Secondly, one can download an SBML version of the model from the same web site for use with any software that reads this standard format. Thirdly, we have introduced the model and all the mutant scenarios discussed in this article into JigCell, our problem-solving environment for biological network modeling (95–97). The parameter sets in the JigCell version of budding yeast and fission yeast are slightly different from the parameter sets presented in this article. The revised parameter values give better fits to the phenotypic details of yeast mutants. JigCell is especially suited to this sort of parameter twiddling to optimize the fit of a model to experimental details. SUPPLEMENTARY MATERIAL An online supplement to this article can be found by visiting BJ Online at http://www.biophysj.org. Acknowledgments We thank Jason Zwolak for help with the Supplementary Material and Akos Sveiczer for useful discussions. This research was supported by grants from Defense Advanced Research Project Agency (AFRL F30602-02-0572), the James S. McDonnell Foundation (21002050), and the European Commission (COMBIO, LSHG-CT-503568). A.C-N. is a Bolyai fellow of the Hungarian Academy of Sciences. APPENDIX: A DYNAMICAL PERSPECTIVE ON MOLECULAR CELL BIOLOGY A molecular regulatory network, such as Fig. 1 Given specific values for the parameters and initial conditions (state variables at time = 0), the differential equations determine how the regulatory network will evolve in time. The direction and speed of this change can be represented by a vector field in a multidimensional state space (Fig. 9 A
As parameters of the system are changed, the number and stability of steady states and periodic orbits may change, e.g., going from Fig. 9, A to B To visualize bifurcations graphically, one plots on the ordinate a representative variable of the dynamical system, as an indicator of the system's state, and on the abscissa, a particular parameter whose changes can induce the bifurcation (Fig. 9 D Following standard conventions, we plot steady-state solutions by lines: solid for stable steady states and dashed for unstable. For limit cycles, we plot two loci: one for the maximum and one for the minimum value of Cdk1/CycB activity on the periodic solution, denoting stable limit cycles with solid circles and unstable with open circles. A locus of steady states can fold back on itself at a saddle-node (SN) bifurcation point (where a stable steady state—a node—and an unstable steady state—a saddle—come together and annihilate one another). Between the two SN bifurcation points in Fig. 9 D Positive feedback is often associated with bistability of a control system. For example, if X activates Y and Y activates X, then the system may persist in a stable “off” state (X low and Y low) or in a stable “on” state (X high and Y high). Similarly, if X inhibits Y and Y inhibits X (double-negative feedback), the system may also persist in either of two stable steady states (X high and Y low, or X low and Y high). Typically, bistability is observed over a range of parameter values (kSN1 < k < kSN2). Negative feedback (X activates Y, which activates Z, which inhibits X) may lead to sustained oscillations of X, Y, and Z, for appropriate choices of reaction kinetics and rate constants. These oscillations typically arise by a Hopf bifurcation, with a stable steady state for k < kHB giving way to stable oscillations for k > kHB. In Table 2 we provide a catalog of common codimension-one bifurcations (bifurcations that can be located, in principle, by changing a single parameter of the system). From a one-parameter bifurcation diagram, properly interpreted, one can reconstruct the vector field (see lines A, B, and C in Fig. 9 D TABLE 2 Definitions and examples of codimension-one and -two bifurcations
To continue this process of abstraction, we go from a one-parameter bifurcation diagram to a two-parameter bifurcation diagram (Fig. 10 In the one-parameter bifurcation diagram, we choose as the primary bifurcation parameter some physiologically relevant quantity (the “signal”) that is inducing a change in behavior (the “response”) of the molecular regulatory system. In the two-parameter diagram, we propose to use the second parameter as an indicator of a genetic characteristic of the cell (the level of expression of a particular gene, above and below the wild-type value) with bearing on the signal-response curve. In this format, the two-parameter bifurcation diagram provides a highly condensed summary of the dynamical links from a controlling gene to its physiological outcome (its phenotypes). The two-parameter diagram captures the sequence of dynamically distinct changes that must occur in carrying phenotype of a wild-type cell to the observed phenotypes of deletion mutants (at one extreme) and overexpression mutants (at the other extreme). In between, there may be novel, physiologically distinct phenotypes that could not be anticipated by intuition alone. Examples of this analysis are provided in Figs. 3 References 1. Rupes, I. 2002. Checking cell size in yeast. Trends Genet. 18:479–485. [PubMed] 2. Sveiczer, A., B. Novak, and J. M. Mitchison. 1996. The size control of fission yeast revisited. J. Cell Sci. 109:2947–2957. [PubMed] 3. Nurse, P. 1994. Ordering S phase and M phase in the cell cycle. Cell. 79:547–550. [PubMed] 4. Hartwell, L. H., and T. A. Weinert. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science. 246:629–634. [PubMed] 5. Nasmyth, K. 1996. Viewpoint: putting the cell cycle in order. Science. 274:1643–1645. [PubMed] 6. Tyson, J. J. 1985. The coordination of cell growth and division—intertional or incidental. Bioessays. 2:72–77. 7. Kastan, M. B., and J. Bartek. 2004. Cell-cycle checkpoints and cancer. Nature. 432:316–323. [PubMed] 8. Cross, F. R., V. Archambault, M. Miller, and M. Klovstad. 2002. Testing a mathematical model for the yeast cell cycle. Mol. Biol. Cell. 13:52–70. [PubMed] 9. Nurse, P. 1992. Eukaryotic cell-cycle control. Biochem. Soc. Trans. 20:239–242. [PubMed] 10. Nurse, P. 1990. Universal control mechanism regulating onset of M-phase. Nature. 344:503–508. [PubMed] 11. Bray, D. 1995. Protein molecules as computational elements in living cells. Nature. 376:307–312. [PubMed] 12. Aguda, B. D. 1999. A quantitative analysis of the kinetics of the G2 DNA damage checkpoint system. Proc. Natl. Acad. Sci. USA. 96:11352–11357. [PubMed] 13. Aguda, B. D. 1999. Instabilities in phosphorylation-dephosphorylation cascades and cell cycle checkpoints. Oncogene. 18:2846–2851. [PubMed] 14. Chen, K. C., A. Csikasz-Nagy, B. Gyorffy, J. Val, B. Novak, and J. J. Tyson. 2000. Kinetic analysis of a molecular model of the budding yeast cell cycle. Mol. Biol. Cell. 11:369–391. [PubMed] 15. Chen, K. C., L. Calzone, A. Csikasz-Nagy, F. R. Cross, B. Novak, and J. J. Tyson. 2004. Integrative analysis of cell cycle control in budding yeast. Mol. Biol. Cell. 15:3841–3862. [PubMed] 16. Goldbeter, A. 1991. A minimal cascade model for the mitotic oscillator involving cyclin and cdc2 kinase. Proc. Natl. Acad. Sci. USA. 88:9107–9111. [PubMed] 17. Gonze, D., and A. Goldbeter. 2001. A model for a network of phosphorylation-dephosphorylation cycles displaying the dynamics of dominoes and clocks. J. Theor. Biol. 210:167–186. [PubMed] 18. Novak, B., and J. J. Tyson. 1993. Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos. J. Cell Sci. 106:1153–1168. [PubMed] 19. Novak, B., and J. J. Tyson. 1995. Quantitative analysis of a molecular model of mitotic control in fission yeast. J. Theor. Biol. 173:283–305. 20. Obeyesekere, M. N., J. R. Herbert, and S. O. Zimmerman. 1995. A model of the G1 phase of the cell cycle incorporating cyclinE/cdk2 complex and retinoblastoma protein. Oncogene. 11:1199–1205. [PubMed] 21. Obeyesekere, M. N., E. Tecarro, and G. Lozano. 2004. Model predictions of MDM2 mediated cell regulation. Cell Cycle. 3:655–661. [PubMed] 22. Qu, Z. L., J. N. Weiss, and W. R. MacLellan. 2003. Regulation of the mammalian cell cycle: a model of the G(1)-to-S transition. Am. J. Physiol. Cell Physiol. 284:C349–C364. [PubMed] 23. Qu, Z. L., J. N. Weiss, and W. R. MacLellan. 2004. Coordination of cell growth and cell division: a mathematical modeling study. J. Cell Sci. 117:4199–4207. [PubMed] 24. Steuer, R. 2004. Effects of stochasticity in models of the cell cycle: from quantized cycle times to noise-induced oscillations. J. Theor. Biol. 228:293–301. [PubMed] 25. Sveiczer, A., A. Csikasz-Nagy, B. Gyorffy, J. J. Tyson, and B. Novak. 2000. Modeling the fission yeast cell cycle: quantized cycle times in wee1-cdc25Δ mutant cells. Proc. Natl. Acad. Sci. USA. 97:7865–7870. [PubMed] 26. Swat, M., A. Kel, and H. Herzel. 2004. Bifurcation analysis of the regulatory modules of the mammalian G(1)/S transition. Bioinformatics. 20:1506–1511. [PubMed] 27. Thron, C. D. 1991. Mathematical analysis of a model of the mitotic clock. Science. 254:122–123. [PubMed] 28. Thron, C. D. 1997. Bistable biochemical switching and the control of the events of the cell cycle. Oncogene. 15:317–325. [PubMed] 29. Tyson, J. J. 1991. Modeling the cell division cycle: cdc2 and cyclin interactions. Proc. Natl. Acad. Sci. USA. 88:7328–7332. [PubMed] 30. Cross, F. R. 2003. Two redundant oscillatory mechanisms in the yeast cell cycle. Dev. Cell. 4:741–752. [PubMed] 31. Marlovits, G., C. J. Tyson, B. Novak, and J. J. Tyson. 1998. Modeling M-phase control in Xenopus oocyte extracts: the surveillance mechanism for unreplicated DNA. Biophys. Chem. 72:169–184. [PubMed] 32. Zwolak, J. W., J. J. Tyson, and L. T. Watson. 2005. Globally optimized parameters for a model of mitotic control in frog egg extracts. IEE Proc. Syst. Biol. 152:81–92. 33. Borisuk, M. T., and J. J. Tyson. 1998. Bifurcation analysis of a model of mitotic control in frog eggs. J. Theor. Biol. 195:69–85. [PubMed] 34. Battogtokh, D., and J. J. Tyson. 2004. Bifurcation analysis of a model of the budding yeast cell cycle. Chaos. 14:653–661. [PubMed] 35. Novak, B., Z. Pataki, A. Ciliberto, and J. J. Tyson. 2001. Mathematical model of the cell division cycle of fission yeast. Chaos. 11:277–286. [PubMed] 36. Tyson, J. J., K. Chen, and B. Novak. 2001. Network dynamics and cell physiology. Nat. Rev. Mol. Cell Biol. 2:908–916. [PubMed] 37. Tyson, J. J., A. Csikasz-Nagy, and B. Novak. 2002. The dynamics of cell cycle regulation. Bioessays. 24:1095–1109. [PubMed] 38. Qu, Z. L., W. R. MacLellan, and J. N. Weiss. 2003. Dynamics of the cell cycle: checkpoints, sizers, and timers. Biophys. J. 85:3600–3611. [PubMed] 39. Novak, B., and J. J. Tyson. 1997. Modeling the control of DNA replication in fission yeast. Proc. Natl. Acad. Sci. USA. 94:9147–9152. [PubMed] 40. Novak, B., A. Csikasz-Nagy, B. Gyorffy, K. Chen, and J. J. Tyson. 1998. Mathematical model of the fission yeast cell cycle with checkpoint controls at the G1/S, G2/M and metaphase/anaphase transitions. Biophys. Chem. 72:185–200. [PubMed] 41. Novak, B., and J. J. Tyson. 2004. A model for restriction point control of the mammalian cell cycle. J. Theor. Biol. 230:563–579. [PubMed] 42. XPP/XPPAUT. 2005. http://www.math.pitt.edu/~bard/xpp/xpp.html. [Online.]. 43. Generic Cell Cycle Model. 2006. http://mpf.biol.vt.edu/research/generic_model/main/pp/. [Online.]. 44. Giot, L., J. S. Bader, C. Brouwer, A. Chaudhuri, B. Kuang, Y. Li, Y. L. Hao, C. E. Ooi, B. Godwin, E. Vitols, G. Vijayadamodar, P. Pochart, et al. 2003. A protein interaction map of Drosophila melanogaster. Science. 302:1727–1736. [PubMed] 45. Kohn, K. W. 1999. Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol. Biol. Cell. 10:2703–2734. [PubMed] 46. Schwikowski, B., P. Uetz, and S. Fields. 2000. A network of protein-protein interactions in yeast. Nat. Biotechnol. 18:1257–1261. [PubMed] 47. Uetz, P., L. Giot, G. Cagney, T. A. Mansfield, R. S. Judson, J. R. Knight, D. Lockshon, V. Narayan, M. Srinivasan, P. Pochart, A. Qureshi-Emili, Y. Li, B. Godwin, et al. 2000. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature. 403:623–627. [PubMed] 48. Uetz, P., and M. J. Pankratz. 2004. Protein interaction maps on the fly. Nat. Biotechnol. 22:43–44. [PubMed] 49. Fantes, P., and P. Nurse. 1977. Control of cell size at division in fission yeast by a growth-modulated size control over nuclear division. Exp. Cell Res. 107:377–386. [PubMed] 50. Johnston, G. C., C. W. Ehrhardt, A. Lorincz, and B. L. A. Carter. 1979. Regulation of cell size in the yeast Saccharomyces cerevisiae. J. Bacteriol. 137:1–5. [PubMed] 51. Jorgensen, P., and M. Tyers. 2004. How cells coordinate growth and division. Curr. Biol. 14:R1014–R1027. [PubMed] 52. Nurse, P. 1975. Genetic control of cell size at cell division in yeast. Nature. 256:547–551. [PubMed] 53. Dolznig, H., F. Grebien, T. Sauer, H. Beug, and E. W. Mullner. 2004. Evidence for a size-sensing mechanism in animal cells. Nat. Cell Biol. 6:899–905. [PubMed] 54. Killander, D., and A. Zetterberg. 1965. A quantitative cytochemical investigation of the relationship between cell mass and initiation of DNA synthesis in mouse fibroblast in vitro. Exp. Cell Res. 40:12–20. [PubMed] 55. Zetterberg, A., and O. Larsson. 1995. Cell cycle progression and cell growth in mammalian cells: kinetic aspects of transition events. In Cell cycle Control. C. Hutchison and D. M. Glover, editors. Oxford University Press. Oxford, UK. 206–227. 56. Baserga, R. 1984. Growth in size and cell DNA replication. Exp. Cell Res. 151:1–4. [PubMed] 57. Conlon, I., and M. Raff. 2003. Differences in the way a mammalian cell and yeast cells coordinate cell growth and cell-cycle progression. J. Biol. 2:7. [PubMed] 58. Murray, A. W., and M. W. Kirschner. 1989. Cyclin synthesis drives the early embryonic cell cycle. Nature. 339:275–280. [PubMed] 59. Solomon, M. J., M. Glotzer, T. H. Lee, M. Philippe, and M. W. Kirschner. 1990. Cyclin activation of p34cdc2. Cell. 63:1013–1024. [PubMed] 60. Futcher, B. 1996. Cyclins and the wiring of the yeast cell cycle. Yeast. 12:1635–1646. [PubMed] 61. Yang, L., Z. Han, W. Robb Maclellan, J. N. Weiss, and Z. Qu. 2006. Linking cell division to cell growth in a spatiotemporal model of the cell cycle. J. Theor. Biol. In press. 62. Moreno, S., and P. Nurse. 1994. Regulation of progression through the G1 phase of the cell cycle by the rum1+ gene. Nature. 367:236–242. [PubMed] 63. Pomerening, J. R., S. Y. Kim, and J. E. Ferrell Jr. 2005. Systems-level dissection of the cell-cycle oscillator: bypassing positive feedback produces damped oscillations. Cell. 122:565–578. [PubMed] 64. Ayte, J., C. Schweitzer, P. Zarzov, P. Nurse, and J. A. DeCaprio. 2001. Feedback regulation of the MBF transcription factor by cyclin Cig2. Nat. Cell Biol. 3:1043–1050. [PubMed] 65. Benito, J., C. Martin-Castellanos, and S. Moreno. 1998. Regulation of the G1 phase of the cell cycle by periodic stabilization and degradation of the p25rum1 CDK inhibitor. EMBO J. 17:482–497. [PubMed] 66. Hayles, J., D. Fisher, A. Woollard, and P. Nurse. 1994. Temporal order of S phase and mitosis in fission yeast is determined by the state of the p34cdc2 -mitotic B cyclin complex. Cell. 78:813–822. [PubMed] 67. Parisi, T., A. R. Beck, N. Rougier, T. McNeil, L. Lucian, Z. Werb, and B. Amati. 2003. Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J. 22:4794–4803. [PubMed] 68. Nurse, P., P. Thuriaux, and K. Nasmyth. 1976. Genetic control of the cell division cycle in the fission yeast Schizosaccharomyces pombe. Mol. Gen. Genet. 146:167–178. [PubMed] 69. Computational Cell Biology at Virginia Tech. 2005. http://mpf.biol.vt.edu/. [Online.]. 70. Tyson, J. J. 1983. Unstable activator models for size control of the cell cycle. J. Theor. Biol. 104:617–631. [PubMed] 71. Tyers, M. 2004. Cell cycle goes global. Curr. Opin. Cell Biol. 16:602–613. [PubMed] 72. Schwob, E., T. Bohm, M. D. Mendenhall, and K. Nasmyth. 1994. The B-type cyclin kinase inhibitor p40sic1 controls the G1 to S transition in S. cerevisiae. Cell. 79:233–244. 73. Visintin, R., S. Prinz, and A. Amon. 1997. CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science. 278:460–463. [PubMed] 74. Zachariae, W., M. Schwab, K. Nasmyth, and W. Seufert. 1998. Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex. Science. 282:1721–1724. [PubMed] 75. Sethi, N., M. C. Monteagudo, D. Koshland, E. Hogan, and D. J. Burke. 1991. The CDC20 gene product of Saccharomyces cerevisiae, a beta-transducin homolog, is required for a subset of microtubule-dependent cellular processes. Mol. Cell. Biol. 11:5592–5602. [PubMed] 76. Fitzpatrick, P. J., J. H. Toyn, J. B. Millar, and L. H. Johnston. 1998. DNA replication is completed in Saccharomyces cerevisiae cells that lack functional Cdc14, a dual-specificity protein phosphatase. Mol. Gen. Genet. 258:437–441. [PubMed] 77. Visintin, R., K. Craig, E. S. Hwang, S. Prinz, M. Tyers, and A. Amon. 1998. The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent phosphorylation. Mol. Cell. 2:709–718. [PubMed] 78. Rudner, A., and A. Murray. 2000. Phosphorylation by Cdc28 activates the Cdc20-dependent activity of the anaphase promoting complex. J. Cell Biol. 149:1377–1390. [PubMed] 79. Irniger, S., M. Baumer, and G. H. Braus. 2000. Glucose and Ras activity influence the ubiquitin ligases APC/C and SCF in Saccharomyces cerevisiae. Genetics. 154:1509–1521. [PubMed] 80. Wasch, R., and F. Cross. 2002. APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit. Nature. 418:556–562. [PubMed] 81. Lew, D. J. 2003. The morphogenesis checkpoint: how yeast cells watch their figures. Curr. Opin. Cell Biol. 15:648–653. [PubMed] 82. Kellogg, D. R. 2003. Wee1-dependent mechanisms required for coordination of cell growth and cell division. J. Cell Sci. 116:4883–4890. [PubMed] 83. Ciliberto, A., B. Novak, and J. J. Tyson. 2003. Mathematical model of the morphogenesis checkpoint in budding yeast. J. Cell Biol. 163:1243–1254. [PubMed] 84. Aguda, B. D., and Y. Tang. 1999. The kinetic origins of the restriction point in the mammalian cell cycle. Cell Prolif. 32:321–335. [PubMed] 85. Obeyesekere, M. N., E. S. Knudsen, J. Y. Wang, and S. O. Zimmerman. 1997. A mathematical model of the regulation of the G1 phase of Rb+/+ and Rb−/− mouse embryonic fibroblasts and an osteosarcoma cell line. Cell Prolif. 30:171–194. [PubMed] 86. Kozar, K., M. A. Ciemerych, V. I. Rebel, H. Shigematsu, A. Zagozdon, E. Sicinska, Y. Geng, Q. Y. Yu, S. Bhattacharya, R. T. Bronson, K. Akashi, and P. Sicinski. 2004. Mouse development and cell proliferation in the absence of D-cyclins. Cell. 118:477–491. [PubMed] 87. Geng, Y., Q. Y. Yu, E. Sicinska, M. Das, J. E. Schneider, S. Bhattacharya, W. M. Rideout, R. T. Bronson, H. Gardner, and P. Sicinski. 2003. Cyclin E ablation in the mouse. Cell. 114:431–443. [PubMed] 88. Malumbres, M., R. Sotillo, D. Santamaria, J. Galan, A. Cerezo, S. Ortega, P. Dubus, and M. Barbacid. 2004. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell. 118:493–504. [PubMed] 89. Ortega, S., I. Prieto, J. Odajima, A. Martin, P. Dubus, R. Sotillo, J. L. Barbero, M. Malumbres, and M. Barbacid. 2003. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat. Genet. 35:25–31. [PubMed] 90. Dirick, L., T. Bohm, and K. Nasmyth. 1995. Roles and regulation of Cln/Cdc28 kinases at the start of the cell cycle of Saccharomyces cerevisiae. EMBO J. 14:4803–4813. [PubMed] 91. Richardson, H. E., C. Wittenberg, F. Cross, and S. I. Reed. 1989. An essential G1 function for cyclin-like proteins in yeast. Cell. 59:1127–1133. [PubMed] 92. Chow, J. P. H., W. Y. Siu, H. T. B. Ho, K. H. T. Ma, C. C. Ho, and R. Y. C. Poon. 2003. Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints. J. Biol. Chem. 278:40815–40828. [PubMed] 93. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell. 100:57–70. [PubMed] 94. Sha, W., J. Moore, K. Chen, A. D. Lassaletta, C.-S. Yi, J. J. Tyson, and J. C. Sible. 2003. Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts. Proc. Natl. Acad. Sci. USA. 100:975–980. [PubMed] 95. Allen, N. A., L. Calzone, K. C. Chen, A. Ciliberto, N. Ramakrishnan, C. A. Shaffer, J. C. Sible, J. J. Tyson, M. T. Vass, L. T. Watson, and J. W. Zwolak. 2003. Modeling regulatory networks at Virginia Tech. OMICS. 7:285–299. [PubMed] 96. Vass, M., N. Allen, C. A. Shaffer, N. Ramakrishnan, L. T. Watson, and J. J. Tyson. 2004. The JigCell model builder and run manager. Bioinformatics. 20:3680–3681. [PubMed] 97. JigCell Project. 2005. http://jigcell.biol.vt.edu/. [Online.]. 98. Kuznetsov, Y. A. 1995. Elements of Applied Bifurcation Theory. Springer Verlag, New York. 99. Strogatz, S. H. 1994. Nonlinear Dynamics and Chaos. Addison-Wesley, Reading, MA. 100. Tyson, J. J., K. C. Chen, and B. Novak. 2003. Sniffers, buzzers, toggles, and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr. Opin. Cell Biol. 15:221–231. [PubMed] 101. Pomerening, J. R., E. D. Sontag, and J. E. Ferrell Jr. 2003. Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2. Nat. Cell Biol. 5:346–351. [PubMed] 102. Kaplan, D., and L. Glass. 1995. Understanding Nonlinear Dynamics, Chapter 5. Springer-Verlag, New York. |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trends Genet. 2002 Sep; 18(9):479-85.
[Trends Genet. 2002]J Cell Sci. 1996 Dec; 109 ( Pt 12)():2947-57.
[J Cell Sci. 1996]Cell. 1994 Nov 18; 79(4):547-50.
[Cell. 1994]Science. 1989 Nov 3; 246(4930):629-34.
[Science. 1989]Science. 1996 Dec 6; 274(5293):1643-5.
[Science. 1996]Mol Biol Cell. 2002 Jan; 13(1):52-70.
[Mol Biol Cell. 2002]Biochem Soc Trans. 1992 May; 20(2):239-42.
[Biochem Soc Trans. 1992]Nature. 1990 Apr 5; 344(6266):503-8.
[Nature. 1990]Nature. 1995 Jul 27; 376(6538):307-12.
[Nature. 1995]Proc Natl Acad Sci U S A. 1999 Sep 28; 96(20):11352-7.
[Proc Natl Acad Sci U S A. 1999]Proc Natl Acad Sci U S A. 1991 Aug 15; 88(16):7328-32.
[Proc Natl Acad Sci U S A. 1991]Dev Cell. 2003 May; 4(5):741-52.
[Dev Cell. 2003]Biophys Chem. 1998 May 5; 72(1-2):169-84.
[Biophys Chem. 1998]J Theor Biol. 1998 Nov 7; 195(1):69-85.
[J Theor Biol. 1998]Bioessays. 2002 Dec; 24(12):1095-109.
[Bioessays. 2002]Proc Natl Acad Sci U S A. 1999 Sep 28; 96(20):11352-7.
[Proc Natl Acad Sci U S A. 1999]Bioinformatics. 2004 Jul 10; 20(10):1506-11.
[Bioinformatics. 2004]Biophys J. 2003 Dec; 85(6):3600-11.
[Biophys J. 2003]Mol Biol Cell. 2004 Aug; 15(8):3841-62.
[Mol Biol Cell. 2004]J Cell Sci. 1993 Dec; 106 ( Pt 4)():1153-68.
[J Cell Sci. 1993]Proc Natl Acad Sci U S A. 2000 Jul 5; 97(14):7865-70.
[Proc Natl Acad Sci U S A. 2000]Proc Natl Acad Sci U S A. 1997 Aug 19; 94(17):9147-52.
[Proc Natl Acad Sci U S A. 1997]J Theor Biol. 2004 Oct 21; 230(4):563-79.
[J Theor Biol. 2004]Science. 2003 Dec 5; 302(5651):1727-36.
[Science. 2003]Nat Biotechnol. 2004 Jan; 22(1):43-4.
[Nat Biotechnol. 2004]J Cell Sci. 1996 Dec; 109 ( Pt 12)():2947-57.
[J Cell Sci. 1996]Exp Cell Res. 1977 Jul; 107(2):377-86.
[Exp Cell Res. 1977]Nature. 1975 Aug 14; 256(5518):547-51.
[Nature. 1975]Nat Cell Biol. 2004 Sep; 6(9):899-905.
[Nat Cell Biol. 2004]Exp Cell Res. 1984 Mar; 151(1):1-5.
[Exp Cell Res. 1984]J Theor Biol. 1998 Nov 7; 195(1):69-85.
[J Theor Biol. 1998]J Cell Sci. 1993 Dec; 106 ( Pt 4)():1153-68.
[J Cell Sci. 1993]Nature. 1994 Jan 20; 367(6460):236-42.
[Nature. 1994]Cell. 2005 Aug 26; 122(4):565-78.
[Cell. 2005]Nature. 1975 Aug 14; 256(5518):547-51.
[Nature. 1975]Bioessays. 2002 Dec; 24(12):1095-109.
[Bioessays. 2002]Nat Cell Biol. 2001 Dec; 3(12):1043-50.
[Nat Cell Biol. 2001]EMBO J. 1998 Jan 15; 17(2):482-97.
[EMBO J. 1998]Cell. 1994 Sep 9; 78(5):813-22.
[Cell. 1994]EMBO J. 2003 Sep 15; 22(18):4794-803.
[EMBO J. 2003]Mol Gen Genet. 1976 Jul 23; 146(2):167-78.
[Mol Gen Genet. 1976]Mol Biol Cell. 2004 Aug; 15(8):3841-62.
[Mol Biol Cell. 2004]Mol Biol Cell. 2004 Aug; 15(8):3841-62.
[Mol Biol Cell. 2004]Exp Cell Res. 1977 Jul; 107(2):377-86.
[Exp Cell Res. 1977]J Bacteriol. 1979 Jan; 137(1):1-5.
[J Bacteriol. 1979]Nature. 1975 Aug 14; 256(5518):547-51.
[Nature. 1975]J Theor Biol. 1983 Oct 21; 104(4):617-31.
[J Theor Biol. 1983]Trends Genet. 2002 Sep; 18(9):479-85.
[Trends Genet. 2002]J Cell Sci. 1996 Dec; 109 ( Pt 12)():2947-57.
[J Cell Sci. 1996]J Bacteriol. 1979 Jan; 137(1):1-5.
[J Bacteriol. 1979]Curr Opin Cell Biol. 2004 Dec; 16(6):602-13.
[Curr Opin Cell Biol. 2004]Exp Cell Res. 1977 Jul; 107(2):377-86.
[Exp Cell Res. 1977]Mol Biol Cell. 2004 Aug; 15(8):3841-62.
[Mol Biol Cell. 2004]Science. 1998 Nov 27; 282(5394):1721-4.
[Science. 1998]Mol Cell Biol. 1991 Nov; 11(11):5592-602.
[Mol Cell Biol. 1991]Mol Gen Genet. 1998 May; 258(4):437-41.
[Mol Gen Genet. 1998]Mol Cell. 1998 Dec; 2(6):709-18.
[Mol Cell. 1998]Dev Cell. 2003 May; 4(5):741-52.
[Dev Cell. 2003]J Cell Biol. 2000 Jun 26; 149(7):1377-90.
[J Cell Biol. 2000]Dev Cell. 2003 May; 4(5):741-52.
[Dev Cell. 2003]Genetics. 2000 Apr; 154(4):1509-21.
[Genetics. 2000]Dev Cell. 2003 May; 4(5):741-52.
[Dev Cell. 2003]Nature. 2002 Aug 1; 418(6897):556-62.
[Nature. 2002]Chaos. 2004 Sep; 14(3):653-61.
[Chaos. 2004]Curr Opin Cell Biol. 2003 Dec; 15(6):648-53.
[Curr Opin Cell Biol. 2003]J Cell Sci. 2003 Dec 15; 116(Pt 24):4883-90.
[J Cell Sci. 2003]J Cell Biol. 2003 Dec 22; 163(6):1243-54.
[J Cell Biol. 2003]Am J Physiol Cell Physiol. 2003 Feb; 284(2):C349-64.
[Am J Physiol Cell Physiol. 2003]Bioinformatics. 2004 Jul 10; 20(10):1506-11.
[Bioinformatics. 2004]Cell Prolif. 1999 Oct; 32(5):321-35.
[Cell Prolif. 1999]Cell Prolif. 1997 Mar-Apr; 30(3-4):171-94.
[Cell Prolif. 1997]J Theor Biol. 2004 Oct 21; 230(4):563-79.
[J Theor Biol. 2004]Cell. 2004 Aug 20; 118(4):477-91.
[Cell. 2004]Cell. 2003 Aug 22; 114(4):431-43.
[Cell. 2003]Cell. 2004 Aug 20; 118(4):493-504.
[Cell. 2004]Nat Genet. 2003 Sep; 35(1):25-31.
[Nat Genet. 2003]EMBO J. 1995 Oct 2; 14(19):4803-13.
[EMBO J. 1995]J Biol Chem. 2003 Oct 17; 278(42):40815-28.
[J Biol Chem. 2003]Cell. 2000 Jan 7; 100(1):57-70.
[Cell. 2000]Nat Rev Mol Cell Biol. 2001 Dec; 2(12):908-16.
[Nat Rev Mol Cell Biol. 2001]Bioessays. 2002 Dec; 24(12):1095-109.
[Bioessays. 2002]Science. 1989 Nov 3; 246(4930):629-34.
[Science. 1989]Science. 1996 Dec 6; 274(5293):1643-5.
[Science. 1996]J Cell Sci. 1993 Dec; 106 ( Pt 4)():1153-68.
[J Cell Sci. 1993]Bioessays. 2002 Dec; 24(12):1095-109.
[Bioessays. 2002]Biophys Chem. 1998 May 5; 72(1-2):185-200.
[Biophys Chem. 1998]OMICS. 2003 Fall; 7(3):285-99.
[OMICS. 2003]Mol Biol Cell. 2004 Aug; 15(8):3841-62.
[Mol Biol Cell. 2004]Nat Rev Mol Cell Biol. 2001 Dec; 2(12):908-16.
[Nat Rev Mol Cell Biol. 2001]Bioessays. 2002 Dec; 24(12):1095-109.
[Bioessays. 2002]Curr Opin Cell Biol. 2003 Apr; 15(2):221-31.
[Curr Opin Cell Biol. 2003]Proc Natl Acad Sci U S A. 2003 Feb 4; 100(3):975-80.
[Proc Natl Acad Sci U S A. 2003]Cell. 2005 Aug 26; 122(4):565-78.
[Cell. 2005]Nat Cell Biol. 2003 Apr; 5(4):346-51.
[Nat Cell Biol. 2003]Trends Genet. 2002 Sep; 18(9):479-85.
[Trends Genet. 2002]Trends Genet. 2002 Sep; 18(9):479-85.
[Trends Genet. 2002]J Theor Biol. 1998 Nov 7; 195(1):69-85.
[J Theor Biol. 1998]